Today (16 May 2022) Prof. Dr. Yong Phuworawan or “Mor Yong” Head of the Center specializing in Clinical Virology Department of Pediatrics Faculty of Medicine Chulalongkorn University Posted via facebook page Yong Poovorawan Note that a large number of studies have been reported to support our study. As can be seen in the latest report published in the journal. Nature Communication
by Swedish researchers The study was conducted in several countries (printed in Nature) and used a lot less samples than us. (Read details from https://www.nature.com/articles/s41467-022-30340-5)
and several studies have shown the same results. as confirmation of each other
- to inject vaccination needlemRNAIt is effective if vaccinated following inactivated vaccine.
From our reports compiled and under consideration for publication in the journal This can be seen in the figure shown. only in the part ofStimulates B cell immunity
But in fact, we did all the studies in detail. published in the Journal of Infectious Disease works well for the species. Omikron too
From the summarized data, it is clear that primary inactivated vaccines, such as Sinovaccin, Sinofarm and pfizer boosters at 5 to 7 months following the 2nd dose, have no difference in results. with 3 doses of pfizer vaccination
different types of vaccinations will go to help each other and make the immune system wider Specifically, stimulation in the T cell system has the same effect. equal to those who have been infected before. and stimulatemRNA vaccine (Study data in Sweden)
In the past Thailand, we lost a lot of this opportunity. However, giving in children is believed to have the same effect.
- The number of booster vaccinations in Thailand
The amount of injectionvaccineCovid-19 of Thailand from February 28, 2021 – May 14, 2022, collecting a total of 135,590,107 doses, divided into the first needle, accumulated 56,515,295 cases, accounting for 81.3% of the population, the second needle, collecting 51,957,050 cases, or 74.7% of the population needle Third place, accumulated 27,117,762 cases, or 39.0% of the population.
